4th Jun 2019 7:00 am |
RNS |
Secures Credit Facilities of up to $20m |
4th Jun 2019 7:00 am |
RNS |
Annual Results for the year ended 31 December 2018 |
21st May 2019 7:00 am |
RNS |
CEO to return to full time duties |
10th Apr 2019 7:20 am |
EQS |
Hardman & Co Research: Tissue Regenix (TRX): Expanded GPO coverage secured |
4th Apr 2019 7:26 am |
RNS |
Expands US GPO coverage for DermaPure |
18th Feb 2019 7:00 am |
RNS |
Change of Adviser |
6th Feb 2019 11:05 am |
RNS |
Second Price Monitoring Extn |
6th Feb 2019 11:00 am |
RNS |
Price Monitoring Extension |
4th Feb 2019 7:00 am |
RNS |
Trading Update |
17th Dec 2018 11:56 am |
EQS |
Hardman & Co Research: Tissue Regenix (TRX): 2018 in review: foundations laid for osteobiologics |
6th Dec 2018 7:00 am |
RNS |
Interim Management Change |
13th Nov 2018 7:00 am |
RNS |
Pan European distribution agreement with Arthrex |
29th Oct 2018 7:00 am |
RNS |
Gareth Jones commences position as CFO |
14th Sep 2018 7:16 am |
EQS |
Hardman & Co Research: Tissue Regenix (TRX): Strategy delivering growth above expectations |
3rd Sep 2018 7:00 am |
RNS |
Unaudited Interim Results |
2nd Aug 2018 10:10 am |
EQS |
Hardman & Co Research: Tissue Regenix (TRX): 1H'18 preview: organic plus inorganic growth |
2nd Aug 2018 7:00 am |
RNS |
Notice of Interim Results |
4th Jul 2018 7:00 am |
RNS |
Appointment of CFO |
25th Jun 2018 7:00 am |
RNS |
HTA License granted and UK distribution Agreement |
21st Jun 2018 7:10 am |
RNS |
TRX BioSurgery wins GPO Supplier Horizon Award |
18th Jun 2018 7:00 am |
RNS |
Issue of Equity |
24th May 2018 12:12 pm |
RNS |
Result of AGM |
2nd May 2018 7:00 am |
RNS |
TRX BioSurgery GPO agreement with Premier, Inc. |
27th Apr 2018 7:00 am |
RNS |
Posting of Annual Report and Notice of AGM |
24th Apr 2018 7:00 am |
RNS |
DermaPure manufacturing at CellRight Facility |
19th Apr 2018 3:29 pm |
RNS |
Holding(s) in Company |
5th Apr 2018 7:17 am |
EQS |
Hardman & Co Research: Tissue Regenix (TRX): CellRight hits the right note |
26th Mar 2018 7:00 am |
RNS |
Annual results for period ended 31 December 2017 |
16th Mar 2018 3:40 pm |
RNS |
Publication of Financial Results |
8th Mar 2018 7:15 am |
RNS |
Hardman & Co: Full-year 2017 - what to look for |
6th Mar 2018 7:00 am |
RNS |
Long term distribution agreement with Arthrex, Inc |
26th Feb 2018 7:00 am |
RNS |
Notice of Results |
26th Feb 2018 7:00 am |
RNS |
Launch of BioSurgery and new distributor agreement |
2nd Feb 2018 7:00 am |
RNS |
Issue of Equity |
22nd Dec 2017 9:30 am |
RNS |
Issue of Equity |
1st Dec 2017 7:00 am |
RNS |
Directorate Change |
1st Dec 2017 7:00 am |
RNS |
Issue of Equity |
2nd Nov 2017 7:00 am |
RNS |
Appointment of CEO |
18th Oct 2017 7:00 am |
RNS |
Directorate Change |
11th Oct 2017 7:15 am |
RNS |
Hardman Research: Dual revenue stream growth |